Ontology highlight
ABSTRACT: Importance
Medicare and many commercial insurers do not cover US Food and Drug Administration-approved weight management medications, such as incretin mimetics (semaglutide, tirzepatide, and liraglutide), bupropion-naltrexone, and phentermine-topiramate).Objectives
To assess older adults' interest in weight management medications and associated characteristics and to understand their perceptions about insurance coverage of weight management medications.Design, setting, and participants
This survey study used cross-sectional data from a nationally representative sample of US adults ages 50 to 80 years from the July 2023 National Poll on Healthy Aging. Data were analyzed from August to November 2023.Main outcomes and measures
Outcomes of interest were estimate
SUBMITTER: Oshman L
PROVIDER: S-EPMC11947835 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature